Jill DeSimone's most recent trade in Praxis Precision Medicines Inc was a trade of 10,520 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Praxis Precision Medicines... | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 10,520 | 10,520 | - | - | Stock Option (Right to Buy) | |
| Oncternal Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 2,200 | 2,200 | - | - | Stock Options | |
| ITeos Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 24,200 | 24,200 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 8,566 | 8,566 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 44,766 | 44,766 | - | - | Stock Option (Right to Buy) | |
| Oncternal Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 25,000 | - | - | Stock Options | |
| Praxis Precision Medicines... | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 28,981 | 28,981 | - | - | Stock Option (Right to Buy) | |
| Kinnate Biopharma Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Oncternal Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 50,000 | 50,000 | - | - | Stock Option | |
| Praxis Precision Medicines... | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 45,511 | 45,511 | - | - | Stock Option (Right to Buy) |